In vitro & in vivo assessment of a herbal formula used topically for bone fracture treatment

Journal of Ethnopharmacology

Volumn 131, Issue 2, 2010, Pages 282-289

  Peng, Li Hua ^a,b   Ko, Chun Hay ^b   Siu, Sum Wing ^b   Koon, Chi Man ^b   Yue, Gar Lee ^b   Cheng, Wai Hing ^b   Lau, Tai Wai ^c   Han, Quan Bin ^b   Ng, Ka Ming ^c   Fung, Kwok Pui ^b   Lau, Clara Bik San ^b   Leung, Ping Chung ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

Fracture healing; Herbal topical therapy; Rabbit closed fracture model; Transdermal absorption

Indexed keywords

ALKALINE PHOSPHATASE; ASPEROSAPONIN VI; EMODIN; FLOS CARTHAMI EXTRACT; FRUCTUS GARDENIAE EXTRACT; GENIPOSIDE; GINSENOSIDE RG1A; HYDROXYSAFFLOR YELLOW A; NITRIC OXIDE; PLANT EXTRACT; RADIX DIPSACI EXTRACT; RAMULUS SAMBUCUS WILLIAMSII EXTRACT; RHIZOMA NOTOGINSENG EXTRACT; RHUBARB EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE STRENGTH; CALLUS; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ABSORPTION; DRUG EFFECT; ENZYME ACTIVITY; EXPERIMENTAL RABBIT; FLOS CARTHAMI; FRACTURE HEALING; FRUCTUS GARDENIAE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MEDICINAL PLANT; NONHUMAN; RADIX DIPSACI; RAMULUS SAMBUCUS WILLIAMSII; RHIZOMA NOTOGINSENG; TIBIA FRACTURE;

ANIMALIA; FLOS; MURINAE; ORYCTOLAGUS CUNICULUS; SAMBUCUS WILLIAMSII;

EID: 77956265939     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.06.039     Document Type: Article

References (32)

1. Aspenberg P. Drugs and fracture repair. Acta Orthopaedica 2005, 76:741-748.
2. Auer J.A., Goodship A., Arnoczky S., Pearce S., Price J., Claes L., Rechenberg B.V., Amtenbrinck M.H., Schneider E., Terpitz R.M., Thiele F., Rippe K.P., Grainger W. Refining animal models in fracture research: seeking consensus in optimising both animal welfare and scientific validity for appropriate biomedical use. BMC Musculoskeletal Disorders 2007, 8:72-85.
3. Busse J.W., Bhandari M. Therapeutic ultrasound and fracture healing: a survey of beliefs and practices. Archives of Physical Medicine and Rehabilitation 2004, 85:1653-1656.
4. Button M.L., Sprague S., Gharsaa O., Latouche S., Bhandari M. Economic evaluation of bone stimulation modalities: a systematic review of the literature. Indian Journal of Orthopaedic 2009, 43:168-174.
5. Carofino B.C., Lieberman J.R. Gene therapy applications for fracture-healing. The Journal of Bone and Joint Surgery 2008, 90:99-110.
6. Chen Z.J., Htay A., Santos W.D., Gillies G.T., Fillmore H.L., Sholley M.M., Broaddus W.C. In vitro angiogenesis by human umbilical vein endothelial cells (HUVEC) induced by three-dimensional co-culture with glioblastoma cells. Journal of Neuro-Oncology 2009, 92:121-128.
7. Childs S.G. Stimulators of bone healing. Biologic and biomechanical. Orthopedic Nursing 2003, 22:421-428.
8. Chinese Pharmacopeia Commission Pharmacopoeia of the People's Republic of China 2010, Chinese Medical Science and Technology Press, Beijing, China.
9. Ciombor D.M., Aaron R.K. The role of electrical stimulation in bone repair. Foot and Ankle Clinics 2005, 10:579-593.
10. Dahabreh Z., Calori G.M., Kanakaris N.K., Nikolaou V.S., Giannoudis P.V. A cost analysis of treatment of tibial fracture nonunion by bone grafting or bone morphogenetic protein-7. International Orthopaedics 2009, 33:1407-1414.
11. Holthusen H., Arndt J.O. Nitric oxide evokes pain at nociceptors of the paravascular tissue and veins in humans. Journal of Physiology 1995, 487:253-258.
12. Inceoĝlu S., Kilinçer C., McLain R.F. Screw design alters the effects of stress relaxation on pullout. Bio-medical materials and engineering 2008, 18:53-60.
13. Khan S.N., Lane J.M. The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in orthopaedic applications. Expert Opinion on Biological Therapy 2004, 4:741-748.
14. Li R., Stewart D.J., Schroeder H.P., Mackinnon E.S., Schemitsch E.H. Effect of cell-based VEGF gene therapy on healing of a segmental bone defect. Journal of Orthopaedic Research 2008, 27:8-14.
15. Lienau J., Schmidt B.K., Peters A., Haschke F., Duda G.N., Perka C., Bail H.J., Schütze N., Jakob F., Schell H. Differential regulation of blood vessel formation between standard and delayed bone healing. Journal of Orthopaedic Research 2009, 27:1133-1140.
16. 1 from Panax ginseng in fluorescent transgenic mice. Vascular Pharmacology 2008, 49:37-43.
17. Ma L.G. Introduction of the Chinese medicine treatment on bone fracture. Modern Journal of Integrated Traditional Chinese and Western Medicine 1998, 7:74-75.
18. Mandracchia V.J., Nelson S.C., Barp E.A. Current concepts of bone healing. Clinics in Podiatric Medicine and Surgery 2001, 18:55-77.
19. Matsuyama J., Ohnishi I., Kageyama T., Oshida H., Suwabe T., Nakamura K. Osteogenesis and angiogenesis in regenerating bone during transverse distraction: quantitative evaluation using a canine model. Clinical Orthopaedics 2005, 433:243-250.
20. Nakagawa H., Kamimura M., Takahara K., Hashidate H., Kawaguchi A., Uchiyama S., Miyasaka T. Changes in total alkaline phosphatase level after hip fracture: comparison between femoral neck and trochanter fractures. Journal of Orthopaedic Science 2006, 11:135-139.
21. Nussler A.K. Inflammation, immunoregulation, and inducible nitric oxide synthase. Journal of Leukocyte Biology 1993, 54:171-178.
22. Palomares K.T., Gleason R.E., Mason Z.D., Cullinane D.M., Einhorn T.A., Gerstenfeld L.C., Morgan E.F. Mechanical stimulation alters tissue differentiation and molecular expression during bone healing. Journal of Orthopaedic Research 2009, 27:1123-1132.
23. Park S.H., O'Connor K., Sung R., McKellop H., Sarmiento A. Comparison of healing process in open osteotomy model and closed fracture model. Journal of Orthopaedic Trauma 1999, 13:114-120.
24. Phillips A.M. Overview of the fracture healing cascade. Injury 2005, 36:S5-S7.
25. Khan S.N., Solaris J., Ramsey K.E., Yang X., Bostrom P.G., Stephan D., Daluiski A. Identification of novel gene expression in healing fracture callus tissue by DNA microarray. The Musculoskeletal Journal of Hospital for Special Surgery 2008, 4:149-160.
26. Schmidmaier G., Wildemann B., Heeger J., Gäbelein T., Flyvbjerg A., Bail H.J., Raschke1 M. Improvement of fracture healing by systemic administration of growth hormone and local application of insulin-like growth factor-1 and transforming growth factor-β1. Bone 2002, 31:165-172.
27. Seebeck P., Bail H.J., Exner C., Schell H., Michel R., Amthauer H., Bragulla H., Duda G.N. Do serological tissue turnover markers represent callus formation during fracture healing?. Bone 2005, 37:669-677.
28. Ramchandi M., et al. Formulation of Topical Drug Delivery Systems. Transdermal and Topical Drug Delivery Systems 1997, Taylor & Francis Group, pp. 420-427.
29. Tosounidis T. Fracture healing and bone repair: an update. Trauma 2009, 11:145-156.
30. Ung C.Y., Li H., Cao Z.W., Li Y.X., Chen Y.Z. Are herb-pairs of traditional Chinese medicine distinguishable from others? Pattern analysis and artificial intelligence classification study of traditionally defined herbal properties. Journal of Ethnopharmacology 2007, 111:371-377.
31. Wang C.C., Huang Y.J., Chen L.G., Lee L.T., Yang L.L. Inducible nitric oxide synthase inhibitors of Chinese herbs III. Rheum palmatum. Planta Medica 2002, 68:869-874.
32. Winn S.R., Uludag H., Hollinger J.O. Carrier systems for bone morphogenetic proteins. Clinical Orthopaedics 1999, 367:95-106.